Caxton Associates LP Purchases Shares of 1,900 Humana Inc (HUM)
Caxton Associates LP purchased a new stake in Humana Inc (NYSE:HUM) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,900 shares of the insurance provider’s stock, valued at approximately $463,000.
A number of other large investors also recently made changes to their positions in HUM. WFG Advisors LP grew its position in Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after acquiring an additional 20 shares during the period. Acrospire Investment Management LLC bought a new stake in Humana in the second quarter valued at $120,000. Northwestern Mutual Wealth Management Co. grew its position in Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after acquiring an additional 325 shares during the period. Fiduciary Trust Co. bought a new stake in Humana in the second quarter valued at $135,000. Finally, ClariVest Asset Management LLC bought a new stake in Humana in the third quarter valued at $144,000. Hedge funds and other institutional investors own 94.19% of the company’s stock.
HUM has been the topic of a number of analyst reports. ValuEngine upgraded Humana from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $273.00 price target on the stock in a research report on Tuesday, October 3rd. Cowen reiterated a “buy” rating and issued a $285.00 price target on shares of Humana in a research report on Wednesday. BidaskClub upgraded Humana from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. Finally, Jefferies Group reiterated a “hold” rating and issued a $257.00 price target on shares of Humana in a research report on Friday, October 13th. Twelve investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $256.30.
Shares of Humana Inc (NYSE:HUM) opened at $256.24 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market capitalization of $36,377.89, a price-to-earnings ratio of 21.73, a PEG ratio of 1.75 and a beta of 0.88. Humana Inc has a 1-year low of $186.25 and a 1-year high of $264.56.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.27 by $0.12. The business had revenue of $13.28 billion for the quarter, compared to analysts’ expectations of $13.41 billion. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the business earned $3.18 earnings per share. research analysts expect that Humana Inc will post 11.63 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.62%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is 12.59%.
WARNING: This report was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/caxton-associates-lp-purchases-shares-of-1900-humana-inc-hum/1763520.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with Analyst Ratings Network's FREE daily email newsletter.